elguapo
Experienced Member
- Reaction score
- 0
According to the Osteoscreen website, it passed phase I clinical trials, which I believe involves approximately 20 people, by definition.
I recently participated in a clinical trial for an unrelated product, and had no luck, so I dropped out. Though I'm not sure if it is THE phase I or if it is some preliminary phase. Either way, I got a first-hand look at why such trials can take so long. I think the main reason is inline with one of the comments the lead doctor made: a lot of research being conducted involves trying compounds that already exist for other unrelated areas of use. Shooting in the dark, basically.
But the other thing I learned is that it isn't uncommon for trials to be going on even though they haven't been publicized. That's why I thought I might ask if anybody has heard anything. Last I heard, they were going to commence phase II trials late this year.
I recently participated in a clinical trial for an unrelated product, and had no luck, so I dropped out. Though I'm not sure if it is THE phase I or if it is some preliminary phase. Either way, I got a first-hand look at why such trials can take so long. I think the main reason is inline with one of the comments the lead doctor made: a lot of research being conducted involves trying compounds that already exist for other unrelated areas of use. Shooting in the dark, basically.
But the other thing I learned is that it isn't uncommon for trials to be going on even though they haven't been publicized. That's why I thought I might ask if anybody has heard anything. Last I heard, they were going to commence phase II trials late this year.